Qualitative functional deficiency of affinity-purified lactoferrin from neutrophils of patients with chronic myelogenous leukemia, and lactoferrin/H-ferritin-cell interactions in a patient with lactoferrin-deficiency with normal numbers of circulating leukocytes

Pathobiology

Volumn 59, Issue 1, 1991, Pages 26-35

  Broxmeyer, Hal E ^a   Bicknell, David C ^a   Cooper, Scott ^a   Sledge, George ^a   Williams, Douglas E ^b   McGuire, Warren A ^a   Coates, Thomas D ^c  

^a INDIANA UNIVERSITY   (United States)

^b AMGEN INC   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Chronic myelogenous leukemia; H ferritin; Lactoferrin; Myelopoiesis; Neutrophils

Indexed keywords

FERRITIN; LACTOFERRIN;

ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; HUMAN; HUMAN CELL; MYELOPOIESIS; NEUTROPHIL; PRIORITY JOURNAL;

ALPROSTADIL; CHROMATOGRAPHY, AFFINITY; COLONY-FORMING UNITS ASSAY; COLONY-STIMULATING FACTORS; DEPRESSION, CHEMICAL; DINOPROSTONE; FERRITIN; HEMATOPOIETIC STEM CELLS; HUMAN; LACTOFERRIN; LEUKEMIA, MYELOID, CHRONIC; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; NEUTROPHILS; SECRETORY RATE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026031322     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000163612     Document Type: Article

References (56)

1. Broxmeyer HE, Williams DE: The production of myeloid blood cells and their regulation during health and disease. CRC Crit Rev Oncol/Hematol 1988;8:173-226.
2. Broxmeyer HE, Williams DE: Actions of hematopoietic colony stimulating factors in vivo. Pathol Immunopathol Res 1987;6: 207-220.
3. Broxmeyer HE, Vadhan-Raj S: Preclinical and clinical studies with the hematopoietic colony stimulating factors and related interleukins. Immunol Res 1989;8:185-201.
4. Broxmeyer HE: The interacting effects of cytokines on hematopoietic stem and progenitor cells; in Mertelsmann R, Herrmann F (eds): Hematopoietic Growth Factors in Clinical Application. New York, Dekker, 1990, in press.
5. Broxmeyer HE: Iron-binding proteins and the regulation of hematopoietic cell proliferation/differentiation; de Sousa M, Brock JH (eds): Iron, Immunity, Cancer and Inflammation. England, Wiley, 1989, pp 199-221.
6. Metz-Boutique MH, Jolles J, Mazurier J, Schoentgen F, Legrand D, Spik G, Montreuil J, Jolles P: Human lactoferrin: Amino acid sequence and structural comparisons with other transferrins. Eur J Biochem 1984;145:659-676.
7. Rado TA, Bollekens J, St. Laurent G, Parker L, Benz EJ Jr.: Lactoferrin biosynthesis during granulopoiesis. Blood 1984;64: 1103-1109.
8. Rado TA, Wei X, Benz EJ Jr.: Isolation of lactoferrin cDNA from a human myeloid library and expression of mRNA during normal and leukemic myelopoiesis. Blood 1987;70:989-993.
9. Olsson I, Lantz M, Persson AM, Arnljots K: Biosynthesis and processing of lactoferrin in bone marrow cells, a comparison with processing of myeloperoxidase. Blood 1988;71:441-447.
10. Baggliolini M, DeDuve C, Masson PL, Heremans JR: Association of lactoferrin with specific granules in rabbit heterophil leukocytes. J Exp Med 1970;131:559-570.
11. Cramer E, Pryzwansky KB, Villeval JL, Testa U, Breton-Gorius J: Ultrastructural localization of lactoferrin and myeloperoxidase in human neutrophils by immunogold. Blood 1985;65:423-432.
12. Levi S, Cescareni G, Arosio P, Lorenzetti R, Soria M, Sollazzo M, Albertini A, Cortese R: Characterization of human ferritin H chain synthesized in Escherichia coli. Gene 1987;51:269-274.
13. Levi S, Salfeld J, Franceschinelli F, Cozzi A, Domer MH, Arosio P: Expression and structural and functional properties of human ferritin L-chain from Escherichia coli. Biochemistry 1989;28: 5179-5184.
14. Broxmeyer HE, Bognacki J, Dorner MH, de Sousa M: The identification of leukemia-associated inhibitory activity (LIA) as acidic isoferritins: A regulatory role for acidic isoferritins in the production of granulocytes and macrophages. J Exp Med 1981: 153:1426-1444.
15. Broxmeyer HE, Lu L, Bicknell DC, Williams DE, Cooper S, Levi S, Salfeld J, Arosio P: The influence of purified recombinant human acidic and basic isoferritins on colony formation in vitro by granulocyte-macrophage and erythroid progenitor cells. Blood 1986;68:1257-1263.
16. Broxmeyer HE, Williams DE, Geissler K, Hangoc G, Cooper S, Levi S, Arosio P: Suppressive effects in vivo of purified recombinant human H-subunit (acidic) ferritin on murine myelopoiesis. Blood 1988;73:74-79.
17. Broxmeyer HE, Mendelson N, Moore MAS: Abnormal granulocyte feedback regulation of colony forming and colony stimulating activity-producing cells from patients with chronic myelogenous leukemia. Leuk Res 1977;1:3-12.
18. Broxmeyer HE, Ralph P, Bognacki J, Kincade P, de Sousa M: A subpopulation of human polymorphonuclear neutrophils contains an active form of lactoferrin capable of inhibiting production of granulocyte-macrophage colony stimulating activities by human monocytes. J Immunol 1980;125:903-909.
19. Broxmeyer HE, Gentile P, Bognacki J, Ralph P: Lactoferrin, transferrin and acidic isoferritins. Regulatory molecules with potential therapeutic value in leukemia. Blood Cells 1983;9:83-105.
20. Broxmeyer HE: In vitro inhibition of mouse granulopoiesis by cell-free activity derived from human polymorphonuclear neutrophils. Blood 1978;51:889-901.
21. Broxmeyer HE, Smithyman A, Eger RR, Meyers PA, de Sousa M: Identification of lactoferrin as the granulocyte-derived inhibitor of colony stimulating activity (CSA)-production. J Exp Med 1978;148:1052-1067.
22. Broxmeyer HE, de Sousa M, Smithyman A, Ralph P, Hamilton J, Kurland JI, Bognacki J: Specificity and modulation of the action of lactoferrin, a negative feedback regulator of myelopoiesis. Blood 1980;55:324-333.
23. Broxmeyer HE, Bicknell DC, Gillis S, Harris EL, Pelus LM, Sledge GW Jr.: Lactoferrin: Affinity purification from human milk and polymorphonuclear neutrophils using monoclonal antibody (II2C) to human lactoferrin, development of an immuno-radiometric assay using II2C, and myelopoietic regulation and receptor-binding characteristics. Blood Cells 1986; 11:429-446.
24. Broxmeyer HE, Platzer E: Lactoferrin acts on I-A and I-E/C antigen-positive subpopulations of mouse peritoneal macrophages in the absence of T-lymphocytes and other cell types to inhibit production of granulocyte-macrophage colony stimulating factors in vitro. J Immunol 1984;133:306-314.
25. Zucali JR, Broxmeyer HE, Levy D, Morse C: Lactoferrin decreases monocyte induced fibroblast production of myeloid colony stimulating activity by suppressing monocyte release of interleukin 1. Blood 1989;74:1531-1536.
26. Bagby GC, Rigas VD, Bennett RM, Vanderbark AA, Garewal HS: Interaction of lactoferrin, monocytes, and T-lymphocyte subsets in the regulation of steady-state granulopoiesis in vitro. J Clin Invest 1981;68:56-63.
27. Bagby GC, McCall E, Bergstram KA, Burger D: A monokine regulates colony-stimulating activity production by vascular endothelial cells. Blood 1983;62:663-668.
28. Bagby GC, McCall E, Layman DL: Regulation of colony-stimulating activity production. Interaction of fibroblasts, mononuclear phagocytes and lactoferrin. J Clin Invest 1983;71:340-344.
29. Zucali JR, Dinarello CA, Obion DJ, Gross MA, Anderson L, Weiner RS: Interleukin-1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest 1986;77:1857-1863.
30. Zucali JR, Broxmeyer HE, Dinarello CA, Gross MA, Weiner RS: Regulation of early human hematopoietic (BFU-E and CFU-GEMM) progenitor cells in vitro by interleukin 1-induced fibroblast conditioned medium. Blood 1987;69:33-37.
31. Bagby GC, Dinarello CA, Wallace P, Wagner C, Hefeneider S, McCall E: Interleukin 1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells. J Clin Invest 1986;78:1316-1323.
32. Sledge GW Jr., Bicknell DC, Harris EL, Zegarra G, Broxmeyer HE: Monoclonal antibody (II2C) to human lactoferrin inactivates the myelopoietic suppressive effect of human lactoferrin in vitro. Exp Hematol 1986;14:333-337.
33. Broxmeyer HE, Gentile P, Cooper S, Lu L, Juliano L, Piacibello W, Meyers PA, Cavanna F: Functional activities of acidic isoferritins and lactoferrin in vitro and in vivo. Blood Cells 1984; 10: 397-426.
34. Breton-Gorius J, Mason DY, Buriot D, Vilde JL, Griscelli C: Lactoferrin deficiency as a consequence of a lack of specific granules in neutrophils from a patient with recurrent infections. Am J Pathol 1980;99:413-428.
35. Strauss RG, Bove KE, Jones JF, Mauer AM, Fulginiti VA: An anomaly of neutrophil morphology with impaired function. N Engl J Med 1974;290:478-484.
36. Boxer LA, Coates TD, Haak RA, Wolach JB, Hoffstein S, Baehner RL: Lactoferrin deficiency associated with altered granulocyte function. N Engl J Med 1982;307:404-410.
37. Parmley RT, Tzeng DY, Baehner RL, Boxer LA: Abnormal distribution of complex carbohydrates in neutrophils of a patient with lactoferrin deficiency. Blood 1983;62:538-548.
38. Lomax KJ, Gallin JI, Rotrosen D, Raphael GD, Kaliner MA, Benz EJ Jr., Boxer LA, Malech HL: Selective defect in myeloid cell lactoferrin gene expression in neutrophil specific granule deficiency. J Clin Invest 1989;83:514-519.
39. Broxmeyer HE, Bognacki J, Ralph P, Dorner MH, Lu L, Castro-Malaspina H: Monocyte-macrophage derived acidic isoferritins: Normal feedback regulators of granulocyte-macrophage progenitor cells. Blood 1982;60:595-607.
40. Williams DE, Cooper S, Broxmeyer HE: The effects of hematopoietic suppressor molecules on the in vitro proliferation of purified murine granulocyte-macrophage progenitor cells (CFU-GM). Cancer Res 1988;48:1548-1550.
41. Broxmeyer HE, Juliano L, Waheed A, Shadduck RK: Release from mouse macrophages of acidic isoferritins that suppress hematopoietic progenitor cells is induced by purified L-cell colony stimulating factors and suppressed by human lactoferrin. J Immunol 1985;135:3224-3231.
42. Kurland JI, Broxmeyer HE, Bockman RS, Moore MAS: Role for monocyte-macrophage colony stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation. Blood 1978;52:388-407.
43. Pelus LM, Broxmeyer HE, Kurland JI, Moore MAS: Regulation of macrophage and granulocyte proliferation: Specificities of prostaglandin E and lactoferrin. J Exp Med 1979; 150:277-292.
44. Broxmeyer HE, Cooper S, Levi S, Arosio A: Mutated recombinant human H-ferritins and myelosuppression in vitro and in vivo: A link between H-ferritin ferroxidase activity and interactions with iron. Proc Natl Acad Sci USA, in press.
45. Taetle R: The role of transferrin receptors in hemopoietic cell growth. Exp Hematol 1990;18:360-365.
46. Nocka KH, Pelus LM: Cell cycle specific effects of deferoxamine on human and murine hematopoietic progenitor cells. Cancer Res 1988:48:3571-3575.
47. Dezza L, Cazzola M, Danova M, Carolo-Stella C, Bergamaschi G, Brugnatelli S, Invemizzi R, Mazzini G, Riccardi A, Ascari E: Effects of desferrioxamine on normal and leukemic human hematopoietic cell growth: In vitro and in vivo studies. Leukemia 1989;3:104-107.
48. Broxmeyer HE: Relationship of cell-cycle expression of Ia-like antigen determinants on normal and leukemia human granulocyte-macrophage progenitor cells to regulation in vitro by acidic isoferritins. J Clin Invest 1982;69:632-642.
49. Broxmeyer HE, Williams DE, Hangoc G, Cooper S, Gentile P, Shen RN, Ralph P, Gillis S, Bicknell DC: The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors. Blood Cells 1987; 13: 31-48.
50. Miyazawa K, Mantel C, Lu L, Morrison DC, Broxmeyer HE: Lactoferrin-lipopolysaccharide interactions: Effect on lactoferrin binding to monocyte/macrophage differentiated HL-60 cells. J Immunol, in press.
51. Broxmeyer HE: Potential therapeutic usefulness of lactoferrin in leukemia. Nestlé Res News 1984/1985:93-99.
52. Broxmeyer HE, Piacibello W, Juliano L, Platzer E, Berman E, Rubin BY: Gamma interferon induces colony forming cells of human monoblast cell line U937 to respond to inhibition by lactoferrin, transferrin and acidic isoferritins. Exp Hematol 1986;14:35-43.
53. Broxmeyer HE, Rubin BY, Berman E, Juliano L, Lu L, Hast LJ, Cooper S, Singer JW: Activities derived from established human myeloid cell lines reverse the suppression of cell line colony formation by lactoferrin and transferrin. Exp Hematol 1986; 14:51-59.
54. Lu L, Shen RN, Lin ZH, Zhou SZ, Harrington M, Srivastava C, Ruscetti S, Broxmeyer HE: Synergistic effect of human lactoferrin (LF) with murine recombinant interferon-gamma (IFN-γ) in mice infected with Friend virus complex (abstract). Exp Hematol 1990:18:634.
55. Gentile P, Broxmeyer HE: Suppression of mouse myelopoiesis by administration of human lactoferrin in vivo and the comparative action of human transferrin. Blood 1983;61:982-993.
56. Estrov Z, Tawa A, Wang XH, Dube ID, Sulh H, Cohen A, Gel-ford EW, Freedman MH: In vitro and in vivo effects of deferoxamine in neonatal acute leukemia. Blood 1987;69:757-761.